Literature DB >> 32625259

EMA and EFSA Joint Scientific Opinion on measures to reduce the need to use antimicrobial agents in animal husbandry in the European Union, and the resulting impacts on food safety (RONAFA).

David Murphy, Antonia Ricci, Zanda Auce, J Gabriel Beechinor, Hanne Bergendahl, Rory Breathnach, Jiří Bureš, João Pedro Duarte Da Silva, Judita Hederová, Peter Hekman, Cornelia Ibrahim, Emil Kozhuharov, Gábor Kulcsár, Eva Lander Persson, Johann M Lenhardsson, Petras Mačiulskis, Ioannis Malemis, Ljiljana Markus-Cizelj, Alia Michaelidou-Patsia, Martti Nevalainen, Paolo Pasquali, Jean-Claude Rouby, Johan Schefferlie, Wilhelm Schlumbohm, Marc Schmit, Stephen Spiteri, Stanko Srčič, Lollita Taban, Toomas Tiirats, Bruno Urbain, Ellen-Margrethe Vestergaard, Anna Wachnik-Święcicka, Jason Weeks, Barbara Zemann, Ana Allende, Declan Bolton, Marianne Chemaly, Pablo Salvador Fernandez Escamez, Rosina Girones, Lieve Herman, Kostas Koutsoumanis, Roland Lindqvist, Birgit Nørrung, Lucy Robertson, Giuseppe Ru, Moez Sanaa, Marion Simmons, Panagiotis Skandamis, Emma Snary, Niko Speybroeck, Benno Ter Kuile, Helene Wahlström, Keith Baptiste, Boudewijn Catry, Pier Sandro Cocconcelli, Robert Davies, Christian Ducrot, Christian Friis, Gregers Jungersen, Simon More, Cristina Muñoz Madero, Pascal Sanders, Marian Bos, Zoltan Kunsagi, Jordi Torren Edo, Rosella Brozzi, Denise Candiani, Beatriz Guerra, Ernesto Liebana, Pietro Stella, John Threlfall, Helen Jukes.   

Abstract

EFSA and EMA have jointly reviewed measures taken in the EU to reduce the need for and use of antimicrobials in food-producing animals, and the resultant impacts on antimicrobial resistance (AMR). Reduction strategies have been implemented successfully in some Member States. Such strategies include national reduction targets, benchmarking of antimicrobial use, controls on prescribing and restrictions on use of specific critically important antimicrobials, together with improvements to animal husbandry and disease prevention and control measures. Due to the multiplicity of factors contributing to AMR, the impact of any single measure is difficult to quantify, although there is evidence of an association between reduction in antimicrobial use and reduced AMR. To minimise antimicrobial use, a multifaceted integrated approach should be implemented, adapted to local circumstances. Recommended options (non-prioritised) include: development of national strategies; harmonised systems for monitoring antimicrobial use and AMR development; establishing national targets for antimicrobial use reduction; use of on-farm health plans; increasing the responsibility of veterinarians for antimicrobial prescribing; training, education and raising public awareness; increasing the availability of rapid and reliable diagnostics; improving husbandry and management procedures for disease prevention and control; rethinking livestock production systems to reduce inherent disease risk. A limited number of studies provide robust evidence of alternatives to antimicrobials that positively influence health parameters. Possible alternatives include probiotics and prebiotics, competitive exclusion, bacteriophages, immunomodulators, organic acids and teat sealants. Development of a legislative framework that permits the use of specific products as alternatives should be considered. Further research to evaluate the potential of alternative farming systems on reducing AMR is also recommended. Animals suffering from bacterial infections should only be treated with antimicrobials based on veterinary diagnosis and prescription. Options should be reviewed to phase out most preventive use of antimicrobials and to reduce and refine metaphylaxis by applying recognised alternative measures.
© 2017 European Medicines Agency and © European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.

Entities:  

Keywords:  alternatives; antimicrobial consumption; antimicrobial resistance; control options; husbandry

Year:  2017        PMID: 32625259      PMCID: PMC7010070          DOI: 10.2903/j.efsa.2017.4666

Source DB:  PubMed          Journal:  EFSA J        ISSN: 1831-4732


  42 in total

1.  The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2018/2019.

Authors: 
Journal:  EFSA J       Date:  2021-04-12

2.  The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2019-2020.

Authors: 
Journal:  EFSA J       Date:  2022-03-29

3.  Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): antimicrobial-resistant Escherichia coli in dogs and cats, horses, swine, poultry, cattle, sheep and goats.

Authors:  Søren Saxmose Nielsen; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Helen Clare Roberts; Hans Spoolder; Karl Ståhl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Francesca Baldinelli; Alessandro Broglia; Lisa Kohnle; Julio Alvarez
Journal:  EFSA J       Date:  2022-05-10

Review 4.  Phenotypic and genotypic detection methods for antimicrobial resistance in ESKAPE pathogens (Review).

Authors:  Mădălina Maria Muntean; Andrei-Alexandru Muntean; Mădălina Preda; Loredana Sabina Cornelia Manolescu; Cerasella Dragomirescu; Mircea-Ioan Popa; Gabriela Loredana Popa
Journal:  Exp Ther Med       Date:  2022-06-09       Impact factor: 2.751

5.  Sulfur Amino Acid Metabolism and the Role of Endogenous Cystathionine-γ-lyase/H2S in Holstein Cows with Clinical Mastitis.

Authors:  Bohao Zhang; Ting Lin; Xu Bai; Xiaoxiao An; Lijun Dai; Jun Shi; Yong Zhang; Xingxu Zhao; Quanwei Zhang
Journal:  Animals (Basel)       Date:  2022-06-04       Impact factor: 3.231

6.  Genomic Insights of Enterococcus faecium UC7251, a Multi-Drug Resistant Strain From Ready-to-Eat Food, Highlight the Risk of Antimicrobial Resistance in the Food Chain.

Authors:  Mireya Viviana Belloso Daza; Giovanni Milani; Claudia Cortimiglia; Ester Pietta; Daniela Bassi; Pier Sandro Cocconcelli
Journal:  Front Microbiol       Date:  2022-06-23       Impact factor: 6.064

7.  A Proteomic Approach to Elucidate the Changes in Saliva and Serum Proteins of Pigs with Septic and Non-Septic Inflammation.

Authors:  María José López-Martínez; José Joaquín Cerón; Alba Ortín-Bustillo; Damián Escribano; Josipa Kuleš; Anđelo Beletić; Ivana Rubić; Juan Carlos González-Sánchez; Vladimir Mrljak; Silvia Martínez-Subiela; Alberto Muñoz-Prieto
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

8.  Escherichia coli Strains Producing Selected Bacteriocins Inhibit Porcine Enterotoxigenic Escherichia coli (ETEC) under both In Vitro and In Vivo Conditions.

Authors:  Matěj Hrala; Juraj Bosák; Lenka Micenková; Jitka Křenová; Matej Lexa; Viktória Pirková; Zuzana Tomáštíková; Ivana Koláčková; David Šmajs
Journal:  Appl Environ Microbiol       Date:  2021-06-25       Impact factor: 4.792

9.  Role played by the environment in the emergence and spread of antimicrobial resistance (AMR) through the food chain.

Authors:  Konstantinos Koutsoumanis; Ana Allende; Avelino Álvarez-Ordóñez; Declan Bolton; Sara Bover-Cid; Marianne Chemaly; Robert Davies; Alessandra De Cesare; Lieve Herman; Friederike Hilbert; Roland Lindqvist; Maarten Nauta; Giuseppe Ru; Marion Simmons; Panagiotis Skandamis; Elisabetta Suffredini; Héctor Argüello; Thomas Berendonk; Lina Maria Cavaco; William Gaze; Heike Schmitt; Ed Topp; Beatriz Guerra; Ernesto Liébana; Pietro Stella; Luisa Peixe
Journal:  EFSA J       Date:  2021-06-17

10.  2018 Survey of factors associated with antimicrobial drug use and stewardship practices in adult cows on conventional California dairies: immediate post-Senate Bill 27 impact.

Authors:  Pius S Ekong; Essam M Abdelfattah; Emmanuel Okello; Deniece R Williams; Terry W Lehenbauer; Betsy M Karle; Joan D Rowe; Sharif S Aly
Journal:  PeerJ       Date:  2021-07-13       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.